SCHEMBL4247654

SCHEMBL4247654

C1CN2CNNC2CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1591982 0.84 HTR6 (0.39)
SCHEMBL19005858 0.80 HTR6 (0.32)
SCHEMBL4077331 0.69
Hydrochloric Acid SCHEMBL6632484 0.67 HTR6 (0.62)
SCHEMBL8694678 0.65 HTR6 (0.39)
SCHEMBL337087 0.64 HTR6 (0.65)
SCHEMBL1874468 0.64
SCHEMBL20651315 0.62
SCHEMBL1591800 0.61 HTR6 (0.35)
SCHEMBL3383922 0.61 HTR6 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247504-A1 Indazole Derivatives for Treatment of Alzheimer's Disease MERCK SHARP & DOHME LIMITED (GB) 2009-10-01 US disclosed
EP-1983981-A1 INDAZOLE DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME LTD. (GB) 2008-10-29 EP disclosed
WO-2007088401-A1 INDAZOLE DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME LIMITED (GB) 2007-08-09 WO disclosed